Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

176 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Serum interleukin 1 in ovarian cancer patients.
Zeisler H, Tempfer C, Joura EA, Sliutz G, Koelbl H, Wagner O, Kainz C. Zeisler H, et al. Among authors: kainz c. Eur J Cancer. 1998 May;34(6):931-3. doi: 10.1016/s0959-8049(97)10107-1. Eur J Cancer. 1998. PMID: 9797710
Significance of serum CA125 and TPS antigen levels for determination of overall survival after three chemotherapy courses in ovarian cancer patients during long-term follow-up.
van Dalen A, Favier J, Hallensleben E, Burges A, Stieber P, de Bruijn HW, Fink D, Ferrero A, McGing P, Harlozinska A, Kainz Ch, Markowska J, Molina R, Sturgeon C, Bowman A, Einarsson R, Goike H. van Dalen A, et al. Among authors: kainz ch. Eur J Gynaecol Oncol. 2009;30(6):609-15. Eur J Gynaecol Oncol. 2009. PMID: 20099488
Serum M3/M21 in ovarian cancer patients.
Tempfer C, Hefler L, Haeusler G, Sliutz G, Hanzal E, Reinthaller A, Kainz CH. Tempfer C, et al. Among authors: kainz ch. Br J Cancer. 1997;76(10):1387-9. doi: 10.1038/bjc.1997.565. Br J Cancer. 1997. PMID: 9374388 Free PMC article.
Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients.
van Dalen A, Favier J, Burges A, Hasholzner U, de Bruijn HW, Dobler-Girdziunaite D, Dombi VH, Fink D, Giai M, McGing P, Harlozinska A, Kainz C, Markowska J, Molina R, Sturgeon C, Bowman A, Einarsson R. van Dalen A, et al. Among authors: kainz c. Gynecol Oncol. 2000 Dec;79(3):444-50. doi: 10.1006/gyno.2000.5982. Gynecol Oncol. 2000. PMID: 11104617 Clinical Trial.
176 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page